Communication on availability of medicines

This page is also available in:

Tuairimí a glacadh on 20/03/2024 - Bureau decision date: 24/10/2023
Reference
CCMI/221-EESC-2023
Opinion Type
Optional
Referral
COM(2023) 672 final
Rapporteur
Danko RELIĆ
Civil Society Organisations - GR III
Croatia
Co-rapporteur
Thomas STUDENT
(Germany
Plenary session number
586
-

On 24 October 2023 the European Commission adopted a set of actions to better prevent and mitigate critical medicine shortages in the EU. Recent critical shortages, including of certain antibiotics last winter, show that continued coordinated action is needed to address supply challenges and to make Europe's medicine supply chains more resilient in the long run. The main objective of the Communication is to prevent and mitigate critical shortages at EU level, focusing in particular on the most critical medicines, for which security of supply in the EU must be ensured at all times.

This Communication builds on the work under the European Health Union, notably the reinforced mandate of the European Medicines Agency and the recently published pharmaceutical reform. It follows a strong call by Member States at the 2023 June European Council, confirmed in Granada in October 2023, and from the European Parliament.

Downloads

Download format:
Download — Tuairim ó CESE: Communication on availability of medicines
pdf
bg
es
cs
da
de
et
el
en
fr
ga
hr
it
lv
lt
hu
mt
nl
pl
pt
ro
sk
sl
fi
sv

Recommended for you